FHA
MRNA icon

First Horizon Advisors’s Moderna MRNA Stock Holding History

First Horizon Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$938 Sell
34
-124
-78% -$3.27K ﹤0.01% 2176
2025
Q1 		$4.48K Buy
158
+64
+68% +$2.27K ﹤0.01% 1827
2024
Q4 		$3.91K Sell
94
-179
-66% -$8.55K ﹤0.01% 1853
2024
Q3 		$18.2K Sell
273
-44
-14% -$4.04K ﹤0.01% 1397
2024
Q2 		$37.6K Buy
317
+22
+7% +$2.78K ﹤0.01% 1049
2024
Q1 		$31.4K Buy
295
+253
+602% +$25.5K ﹤0.01% 1165
2023
Q4 		$4.18K Sell
42
-75
-64% -$6.31K ﹤0.01% 1844
2023
Q3 		$12.1K Buy
117
+31
+36% +$3.46K ﹤0.01% 1442
2023
Q2 		$10.4K Buy
86
+30
+54% +$4K ﹤0.01% 1527
2023
Q1 		$8.6K Sell
56
-20
-26% -$3.3K ﹤0.01% 1611
2022
Q4 		$13.7K Buy
76
+39
+105% +$6.38K ﹤0.01% 1411
2022
Q3 		$3K Sell
37
-54
-59% -$8.19K ﹤0.01% 1909
2022
Q2 		$13K Buy
91
+77
+550% +$11K ﹤0.01% 1473
2022
Q1 		$2K Sell
14
-126
-90% -$21.2K ﹤0.01% 1465
2021
Q4 		$34K Buy
140
+14
+11% +$4.09K ﹤0.01% 1086
2021
Q3 		$48K Buy
126
+101
+404% +$37.2K ﹤0.01% 922
2021
Q2 		$5K Sell
25
-60
-71% -$10.7K ﹤0.01% 1539
2021
Q1 		$11K Buy
85
+22
+35% +$3.19K ﹤0.01% 1262
2020
Q4 		$6K Buy
63
+21
+50% +$2.13K ﹤0.01% 1181
2020
Q3 		$2K Sell
42
-62
-60% -$4.32K ﹤0.01% 1312
2020
Q2 		$6K Buy
+104
New +$5.7K ﹤0.01% 1141

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

First Horizon Advisors's MRNA Position: Q2 2025 in Review

First Horizon Advisors reduced its Moderna (MRNA) stake by 78% in Q2 2025, selling an estimated $3.27K and leaving 34 shares worth $938. The position accounts for ﹤0.01% of the portfolio, ranked #2176.

First Horizon Advisors first reported a position in MRNA in Q2 2020 and has held it in 21 quarters since. The position peaked at $48K in Q3 2021. 675 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • First Horizon Advisors held 34 shares of Moderna worth $938 as of Q2 2025.
  • First Horizon Advisors sold 124 Moderna shares in Q2 2025, an estimated $3.27K.
  • Moderna made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #2176 holding.
  • First Horizon Advisors first reported a position in Moderna in Q2 2020 and has held it in 21 quarters since.
  • First Horizon Advisors's Moderna position peaked at $48K in Q3 2021.
  • 675 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.